Interferon alfa-2b with VMCP compared to VMCP alone for induction and interferon alfa-2b compared to controls for remission maintenance in multiple myeloma: Interim results
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27, S40-S45
- https://doi.org/10.1016/0277-5379(91)90570-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction ChemotherapyNew England Journal of Medicine, 1990
- Interferons in the treatment of multiple myelomaInternational Journal of Cancer, 1987
- Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assayCancer Chemotherapy and Pharmacology, 1983
- Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cellsNature, 1982
- Inhibition of cell division by interferon: Changes in cell cycle characteristics and in morphology of ehrlich ascites tumour cells in cultureJournal of Cell Science, 1981
- In vitro inhibitory effect of interferon on colony formation of myeloma stem cellsCancer Immunology, Immunotherapy, 1980
- Augmentation of human monocyte-mediated cytolysis by interferonCellular Immunology, 1980
- Combination chemotherapy for multiple myelomaCancer, 1972